Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
Aurobindo Pharma announced the completion of the previously announced acquisition of certain commercial operations in Western Europe from Actavis. The agreement to acquire the Actavis operations was announced in January 2014.
Aurobindo Pharma, a mid-size pharmaceutical company, today announce that the company has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Repaglinid... More..
Aurobindo Pharma, plans to complete restructuring and expansion programme during Q4 FY 2001-02. The company plans to achieve a turnover of above Rs 4,000 crore by FY 2005-06 with formulations accounting for 30 per cent. Joint ventures in US and China are expected boost the company`s international revenues. Srinivas Lanka